Investigation of the efficacy and adverse effects of lacosamide over 36 months

MLA

Kei Wakabayashi, et al. “Investigation of the Efficacy and Adverse Effects of Lacosamide over 36 Months.” Epilepsy & Behavior, vol. 144, July 2023, p. 109227. EBSCOhost, https://doi.org/10.1016/j.yebeh.2023.109227.

APA

Kei Wakabayashi, Hitoshi Osaka, Hirokazu Yamagishi, Mari Kuwajima, Takahiro Ikeda, Ayumi Matsumoto, Kazuhiro Muramatsu, & Takanori Yamagata. (2023). Investigation of the efficacy and adverse effects of lacosamide over 36 months. Epilepsy & Behavior, 144, 109227. https://doi.org/10.1016/j.yebeh.2023.109227

Chicago

Kei Wakabayashi, Hitoshi Osaka, Hirokazu Yamagishi, Mari Kuwajima, Takahiro Ikeda, Ayumi Matsumoto, Kazuhiro Muramatsu, and Takanori Yamagata. 2023. “Investigation of the Efficacy and Adverse Effects of Lacosamide over 36 Months.” Epilepsy & Behavior 144 (July): 109227. doi:10.1016/j.yebeh.2023.109227.